Evidence map›Paper›PMID 20949100›Full record

ArticlePloS one2010

Expression of rod-derived cone viability factor: dual role of CRX in regulating promoter activity and cell-type specificity.

Sophie Lambard, Sacha Reichman, Cynthia Berlinicke, Marie-Laure Niepon, Olivier Goureau, José-Alain Sahel, Thierry Léveillard, Donald J Zack

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. UnlockingNAR genomics and bioinformatics · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Preservation of cone photoreceptors after a rapid yet transient degeneration and remodeling in cone-only Nrl-/- mouse retina.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Sophie LambardDepartment of Genetics, INSERM, U968, Paris, France.
Sacha Reichman
Cynthia Berlinicke
Marie-Laure Niepon
Olivier Goureau
José-Alain Sahel
Thierry Léveillard
Donald J Zack
Inserm · FRInstitut de la Vision · FRJohns Hopkins Medicine · US

Funding

REGULATION OF RHODOPSIN GENE EXPRESSIONR01EY009769 · NEI · JOHNS HOPKINS UNIVERSITY · PI ZACK, DONALD J. · 1992 to 2014
$8.1M
NEI NIH HHS R01 EY009769
6 · The paper itself

Abstract

backgroundRdCVF and RdCVF2, encoded by the nucleoredoxin-like genes NXNL1 and NXNL2, are trophic factors with therapeutic potential that are involved in cone photoreceptor survival. Studying how their expression is regulated in the retina has implications for understanding both their activity and the mechanisms determining cell-type specificity within the retina. METHODOLOGY/PRINCIPAL

findingsIn order to define and characterize their promoters, a series of luciferase/GFP reporter constructs that contain various fragments of the 5'-upstream region of each gene, both murine and human, were tested in photoreceptor-like and non-photoreceptor cell lines and also in a biologically more relevant mouse retinal explant system. For NXNL1, 5'-deletion analysis identified the human -205/+57 bp and murine -351/+51 bp regions as having promoter activity. Moreover, in the retinal explants these constructs drove expression specifically to photoreceptor cells. For NXNL2, the human -393/+27 bp and murine -195/+70 bp regions were found to be sufficient for promoter activity. However, despite the fact that endogenous NXNL2 expression is photoreceptor-specific within the retina, neither of these DNA sequences nor larger upstream regions demonstrated photoreceptor-specific expression. Further analysis showed that a 79 bp NXNL2 positive regulatory sequence (-393 to 315 bp) combined with a 134 bp inactive minimal NXNL1 promoter fragment (-77 to +57 bp) was able to drive photoreceptor-specific expression, suggesting that the minimal NXNL1 fragment contains latent elements that encode cell-type specificity. Finally, based on bioinformatic analysis that suggested the importance of a CRX binding site within the minimal NXNL1 fragment, we found by mutation analysis that, depending on the context, the CRX site can play a dual role. CONCLUSIONS/SIGNIFICANCE: The regulation of the Nucleoredoxin-like genes involves a CRX responsive element that can act as both as a positive regulator of promoter activity and as a modulator of cell-type specificity.

Indexed as

Promoter Regions, GeneticAnimalsBase SequenceCell LineDNAElectrophoresis, Polyacrylamide GelElectroporationGreen Fluorescent ProteinsHomeodomain ProteinsHumansMiceMolecular Sequence DataSequence DeletionThioredoxinsTrans-ActivatorsTranscription, Geneticcone rod homeobox proteinDNAGreen Fluorescent ProteinsHomeodomain ProteinsNXNL1 protein, humanThioredoxinsTrans-Activators

Identifiers

PMID20949100
PMCPMC2951342
OpenAlexW2013177207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.